Cetaphil Appears in 67.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Answer Capsule

In November 2026, Cetaphil appeared in 518 of 773 AI answers included in the Dermatologist Recommended Skin Care Brands benchmark (67.01%). It received 334 recommendations (43.21%), with 121 Top 3 placements and 33 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

• How do Cetaphil mentions, recommendations and placements compare with its Dermatologist Recommended Skin Care Brands peers?

Cetaphil recorded 518 mentions (67.01%) and 334 recommendations (43.21%) across 773 answers included in the benchmark. Top 3 placements numbered 121; first-place recommendations numbered 33. Framing among its mentions was 353 positive, 165 neutral and 0 negative.

Cetaphil is mentioned in roughly two-thirds of the benchmark answers and recommended in a little under half, so its reach is real but its endorsement share trails the leaders. The gap between mentions and recommendations is where the commercial risk sits: the brand is in the conversation without always being the answer.

Placement is the sharper constraint. Top-three and first-place appearances are a small slice of its recommendations, meaning Cetaphil is often named as one option among several rather than as the pick. For a dermatologist-recommended category, that pattern suggests the brand is credible but not decisive.

Framing is not the problem. Almost all mentions carry positive wording and none are negative, so the shortfall is about being chosen, not about being described badly. The agency would treat recommendation share and placement as the two measures to move, and would not read the positive framing as evidence of endorsement strength.

What changed since last month

Questions This Section Answers

• How did Cetaphil counts and coverage differ across the available monthly snapshots?

From October 2026 to November 2026, Cetaphil's mention count rose from 477 to 518, while its recommendation count fell from 458 to 334. The recommendation rate was 59.48% and 43.21% respectively.

The monthly record shows a split movement: mentions rose from October to November while recommendations fell, and the recommendation rate dropped alongside. Top-three and first-place appearances also moved in opposite directions, with first-place up and top-three down.

These are separate selected samples, so the November figures are not a like-for-like continuation of October. The change in answer totals does not explain the movement in counts or rates, and the report does not establish a cause. The honest reading is that the November sample recorded a weaker recommendation pattern than October.

The agency would flag this as a signal to watch rather than a trend to act on. A single month of divergent movement is a prompt to check the next sample and to look at which questions drove the difference, not a basis for a corrective campaign.

Step 1. Measure

Questions This Section Answers

• What should the agency measure and verify first for Cetaphil?

AI answers contained 1 conflicting claim about Cetaphil: 0 critical, 0 high, 1 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

A visibility comparison sets the competitive frame: Cetaphil's mention and recommendation shares sit below the three brands ahead of it, which tells the client where the gap is widest. That comparison is useful for prioritisation but says nothing on its own about why the gap exists.

The fact-check list is small, with one medium-severity conflicting claim and nothing rated critical or high. That is a manageable starting workload. The ratings order the checking, but they do not establish that the company or a publisher made an error.

The agency would combine both into a baseline scorecard: competitive position on one side, a scoped claim register on the other, each entry with an owner and an evidence requirement. That gives the client a defensible starting point before any page or publisher work begins.

Step 2. Make the website consistent

Questions This Section Answers

• Which recorded claim differences about Cetaphil should be verified before proposed page edits?

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The one disputed topic concerns the price of the Gentle Skin Cleanser, where recorded AI answers give different figures. Both columns are AI claims, not verified company facts, so the first task is to establish the entity, the date and the source behind each figure.

Different dates can explain an apparent conflict, and a price range and a single figure may simply describe different things. The agency would not decide which claim is true from the report alone. It would verify against current primary sources before any correction is considered.

If verification shows the site is accurate, the outcome is a no-change decision recorded with its evidence. If it shows a genuine gap, a page brief follows, built on approved facts. Either way the client gets a documented decision rather than an open question.

Step 3. Align the external narrative

Questions This Section Answers

• Which cited third-party pages are relevant to fact review for Cetaphil?

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review range from a retailer product page to major editorial roundups, and several carry the conflicting claim. Citation volume is concentrated in a few editorial pages, which makes them the natural first stop for a source review.

A citation does not establish that a page influenced an answer, and a page linked to a conflicting claim is not necessarily its cause. The agency would check current page contents before forming a view, then decide whether an evidence-backed request to a publisher is justified.

Requests would be specific and grounded in verified facts, with no assumption of publisher control or error. Where no case exists, the decision is recorded as no action, which keeps the client's outreach credible and focused.

Step 4. Optimize priority company pages

Questions This Section Answers

• Which observed Cetaphil website pages should receive review briefs?

The company's website was cited 4 times across 4 distinct page addresses; the table shows 4 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company site was cited a handful of times across a small set of pages, covering a cleanser, a moisturizer, an eczema-approved range page and a skincare-tips article. Citation counts are low, and a cited page is not automatically one that accompanied a recommendation.

The zeros in the recommending column are informative: those pages appeared in answers without a matching recommendation. That does not prove the page caused the absence, but it marks them as worth a closer look.

The agency would prepare page briefs for the listed pages using approved facts and the questions buyers actually ask. Each brief would state what the page should answer clearly, and existing coverage would be checked before proposing anything new.

Step 5. Publish around buyer questions

Questions This Section Answers

• Which observed buyer questions support content briefs for Cetaphil?

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The observed questions cluster around cleanser choice, dermatologist recommendations, use alongside tretinoin and general brand rankings. Cetaphil appears in the answers to most of them, and is recommended in most but not all, with the shortfall concentrated in the gentler-cleanser and tretinoin-adjacent questions.

These are recorded answer observations, not search volume or proof of missing website content. The agency would treat them as prompts for content briefs, not as a demand forecast.

Briefs would address the buyer question directly, using approved product facts and clear guidance on routine use. Existing pages would be checked first, so the client adds content only where a genuine gap exists.

Our 90-day action plan

Questions This Section Answers

• How should the agency sequence the proposed Cetaphil work and judge completion?

The first month establishes the baseline: a scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner, an evidence requirement and a review status. Nothing is corrected in this phase.

The second month turns verified findings into approved page briefs and, where justified, publisher requests. Confirmed edits, no-change decisions, requests and responses are recorded separately so the client can see what was decided and why.

The third month produces buyer-content briefs and a fresh scorecard. Completed work is recorded separately from measured answer outcomes, with comparability limits noted. Delivered work is not the same as a visibility gain, and the plan does not promise one.

Methodology

Questions This Section Answers

• How are Cetaphil answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 773 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5811 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The report covers a single month, and the exact dates when the original AI answers were collected have not been verified. Visibility rates rest on the answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording.

An answer can mention or recommend several companies, so company counts cannot be added to find distinct answers. Sentiment describes answer wording, not customer satisfaction. The wider citation analysis covers a larger set of captured answers, and citation appearances differ from benchmark citations and recommendations.

Monthly samples differ, so comparisons show how recorded results changed, not why. Current page contents and disputed claims still need independent verification.

Our first three priorities

First, verify the cleanser price claim against current primary sources and record the outcome, whether that is a correction or a no-change decision. This is the only disputed topic and it is contained, so it can be closed quickly and cleanly.

Second, prepare page briefs for the listed company pages, starting with those cited without a matching recommendation. The aim is to make each page answer the buyer question plainly using approved facts, not to chase citation counts.

Third, build buyer-question content around cleanser choice and use with tretinoin, checking existing coverage first. Alongside this, keep the recommendation and placement gap in view through the scorecard, so the client sees whether the weaker November pattern persists in the next sample.